- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Tianjin Zhongxin Pharmaceutical Group Corp Ltd (600329)
Tianjin Zhongxin Pharmaceutical Group Corp Ltd stock price live, this page displays SS 600329 stock exchange data. View the 600329 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Tianjin Zhongxin Pharmaceutical Group Corp Ltd real time stock price chart below.
What Is the Tianjin Zhongxin Pharmaceutical Group Corp Ltd Stock Price Today?
The Tianjin Zhongxin Pharmaceutical Group Corp Ltd stock price today is 40.60.
What Is the Stock Symbol for Tianjin Zhongxin Pharmaceutical Group Corp Ltd?
The stock symbol for Tianjin Zhongxin Pharmaceutical Group Corp Ltd is "600329."
What Stock Exchange Does Tianjin Zhongxin Pharmaceutical Group Corp Ltd Trade On?
Tianjin Zhongxin Pharmaceutical Group Corp Ltd is listed and trades on the Shanghai stock exchange.
Is Tianjin Zhongxin Pharmaceutical Group Corp Ltd a Good Stock to Buy?
Determining whether Tianjin Zhongxin Pharmaceutical Group Corp Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 600329 quote. (ISIN: CNE000001808)
What Is the Tianjin Zhongxin Pharmaceutical Group Corp Ltd Stock Price Today?
The Tianjin Zhongxin Pharmaceutical Group Corp Ltd stock price today is 40.60.
What Is the Stock Symbol for Tianjin Zhongxin Pharmaceutical Group Corp Ltd?
The stock symbol for Tianjin Zhongxin Pharmaceutical Group Corp Ltd is "600329."
What Stock Exchange Does Tianjin Zhongxin Pharmaceutical Group Corp Ltd Trade On?
Tianjin Zhongxin Pharmaceutical Group Corp Ltd is listed and trades on the Shanghai stock exchange.
Is Tianjin Zhongxin Pharmaceutical Group Corp Ltd a Good Stock to Buy?
Determining whether Tianjin Zhongxin Pharmaceutical Group Corp Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 600329 quote. (ISIN: CNE000001808)
40.60
+0.64(+1.60%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
40.39
41.35
52 wk Range
29.45
50.97
High dividend Yield
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
40.3941.35
52 wk Range
29.4550.97
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(9.33%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(9.33%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
600329 Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PricePrice Target
0.00
Downside
-100.00%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a low earnings multiple
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy
Analyst Ratings
1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 0.00
Earnings
Latest Release
Apr 30, 2026
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
Compare 600329 to Peers and Sector
Metrics to compare | 600329 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship600329PeersSector | |
|---|---|---|---|---|
P/E Ratio | 13.1x | 19.5x | −0.5x | |
PEG Ratio | −3.15 | 1.00 | 0.00 | |
Price/Book | 3.9x | 2.5x | 2.6x | |
Price / LTM Sales | 5.7x | 3.2x | 3.2x | |
Upside (Analyst Target) | - | 28.0% | 47.8% | |
Fair Value Upside | Unlock | 15.1% | 6.7% | Unlock |
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited engages in the research, development, processing, manufacturing, and sale of traditional Chinese medicine in China. It provides pharmaceutical products for cardiovascular and cerebrovascular, skin wound repair, health preservation, respiratory, digestion, rheumatism and osteodynia, urological, gynecological and pediatric, ophthalmological, tumor, chronic, and other diseases, as well as tonic drugs. The company was formerly known as Tianjin Zhong Xin Pharmaceutical Group Corporation Limited and changed its name to Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited in May 2022. The company was founded in 1915 and is based in Tianjin, the People’s Republic of China.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Tianjin Zhongxin Pharm (600329) Stock Price Today?
The Tianjin Zhongxin Pharm stock price today is 40.60 CNY.
What Stock Exchange Does Tianjin Zhongxin Pharm Trade On?
Tianjin Zhongxin Pharm is listed and trades on the Shanghai Stock Exchange.
What Is the Stock Symbol for Tianjin Zhongxin Pharm?
The stock symbol for Tianjin Zhongxin Pharm is "600329."
Does Tianjin Zhongxin Pharm Pay Dividends? What’s The Current Dividend Yield?
The Tianjin Zhongxin Pharm dividend yield is 9.33%.
What Is the Tianjin Zhongxin Pharm Market Cap?
As of today, Tianjin Zhongxin Pharm market cap is 27.83B CNY.
What Is Tianjin Zhongxin Pharm's Earnings Per Share (TTM)?
The Tianjin Zhongxin Pharm EPS (TTM) is 2.77.
When Is the Next Tianjin Zhongxin Pharm Earnings Date?
Tianjin Zhongxin Pharm will release its next earnings report on Apr 30, 2026.
From a Technical Analysis Perspective, Is 600329 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.
How Many Times Has Tianjin Zhongxin Pharm Stock Split?
Tianjin Zhongxin Pharm has split 2 times.
How Many Employees Does Tianjin Zhongxin Pharm Have?
Tianjin Zhongxin Pharm has 3890 employees.
What is the current trading status of Tianjin Zhongxin Pharm (600329)?
As of May 02, 2026, Tianjin Zhongxin Pharm (600329) is trading at a price of 40.60 CNY, with a previous close of 39.96 CNY. The stock has fluctuated within a day range of 40.39 CNY to 41.35 CNY, while its 52-week range spans from 29.45 CNY to 50.97 CNY.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.